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Poster Session II S359There was no difference, however, between MMF and MTX in inci-
dence of grade II-IV aGVHD (pooled RR 5 0.99 (95%CI, 0.83,
1.18; p 5 0.87)), incidence of cGVHD (pooled RR 5 1.01 (95%CI,
0.83, 1.22; p 5 0.95)), relapse risk (pooled RR 5 0.97 (95%CI,
0.68,1.38; p 5 0.86)), NRM (pooled RR 5 0.91 (95%CI, 0.60, 1.37;
p5 0.64)) or OS (pooled HR5 0.83 (95%CI, 0.58, 1.20; p5 0.33)).
Conclusion: critical appraisal of available evidence appears limited/
weak to recommend one particular agent, MMF or MTX, to com-
bine with a calcineurin inhibitor as the preferred aGVHD prophy-
laxis regimen. A large randomized controlled trial that compares
MMF and MTX is needed to address this issue. But, identifying
the most optimal doses and schedules of administration of MMF
and MTX is necessary beforehand.419
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Graft-versus-host disease (GVHD) is a severe complication of mul-
tiple organ systems in allogeneic hematopoietic stem cell transplanta-
tion (HSCT). An association between neurological complications and
GVHDhas been reported in patients after allogeneicHSCT. In amu-
rine MHC-disparate allogeneic transplantation model (BM and T
cells from C57BL/6 into lethally irradiated BALB/c) we studied
whether the CNS is a target organ of acute GVHD.
CNS infiltrating lymphocytes were isolated frombrains after com-
plete perfusion of the animals. We found increasing numbers of
CNS-infiltrating donor derived CD4 and CD8 alloreactive T cells
on day 7, 14, and 21 (p\0.001) in brains from allo-HSCT recipients,
but almost none in syngeneic transplanted controls. The majority of
infiltrating lymphocytes were effector memory T cells
(CD44highCD62Llow). P-selectin-glycoprotein-1, Lymphocyte-
function-associated-antigen-1 and a4-Integrin were broadly and
CXCR-3 was less frequently expressed, while Lymphocyte-Peyer-
patch-adhesion-molecule was absent, the latter distinguishing
CNS infiltrating T cells from peripheral T cells.
Histological analysis and immunohistochemistry for CD3 and
CD4 in situ showed infiltration of Cortex, Hippocampus, Basal gan-
glia, Thalamus, Hypothalamus, Cerebellum, andMedulla oblongata
in allogeneicHSCT recipients, consistent with lymphocyticmultifo-
cal meningoencephalitis. Syngeneic transplanted controls showed no
pathology and T cells were virtually undetectable (p\0.01). Apopto-
tic cell death by TUNEL staining was only observed in allogeneic
transplanted controls.
We performed behavioral tests 14 to 20 days after HSCT to test
whether these findings were associated with cognitive deficits. Mice
were tested before the onset of severe GVHD. We found no differ-
ences between allogeneic- versus syngeneic- or non-transplanted
mice in locomotor activity, motor coordination, strength and neuro-
muscular function. However, allogeneic transplanted animals demon-
strated increased anxious behavior and decreased exploratory activity
(p\0.01). Importantly, spatial learning was impaired in allogeneic
transplanted animals as compared to both controls (p\0.0001).
In conclusion, we observed in our experimental GVHD models
that allo-HSCT recipients incur a lymphocytic meningoencephalitis
during the early stages of acute GVHD, which is associated with sig-
nificant infiltration of donor effectormemoryT cells in the CNS and
certain cognitive defects, such as spatial memory loss.420
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After allogeneic hematopoietic stem-cell transplantation (HSCT),
patients living within one and a half hours’ driving distance to the
unit were given the option of treatment at home after HSCT. An ex-
perienced nurse visited the patient every morning and a phone-call
from a physician was given in the afternoon.
One-hundred and forty-six patients treated at home during the
neutropenic phase were compared to matched hospital controls,
coming from outside Stockholm. Because good oral nutrition was
correlated to reduced acuteGVHD, oral intake was intensified in pa-
tients treated in the hospital from September 2006 (new controls).
We compared four groups; old home-care (before September
2006, n 5 76), new home-care (from September 2006, n 5 70),
old (n 5 76) and new controls (n 5 70).
The cumulative incidence of acute GVHDgrades II – IV was 15%
in the old home-care group, which was significantly lower as op-
posed to 32 – 44% in the new home-care group (p\0.001) and the
two control groups (p\0.03). Cumulative incidence of chronic
GVHD was between 35 and 41% in the four groups.
Transplant-related mortality was between 10 and 24% in the
four groups (n.s.). No patient died at home. Relapse probability
was similar in the four groups. Oral nutrition (kcal/kg/day) dur-
ing the first three weeks was significantly worse in the old con-
trols, as opposed to all other groups (p\0.01). Among the old
controls, oral nutrition was median 18.5 kcal/kg/day, as opposed
to 23.6 kcal/kg/day in the new controls (p 5 0.002). Oral nutri-
tion (p 5 0.02) and days at home (p 5 0.005) were correlated to
low grade of acute GVHD. The new home-care patients spent
fewer days at home (p 5 0.002). In multivariate analysis,
GVHD grades 0-I was associated with home care (HR 2.46, p
5 0.02), days spent at home (HR 0.92, p 5 0.005), but not to
oral nutrition (HR 0.98, p 5 0.13). Despite improved oral intake
in patients treated in the hospital more recently, acute GVHD
did not decrease. The old home-care patients had a decreased
risk of acute GVHD, which probably is due to a long time spent
at home.
Five-year survival was 61% in the home-care group as compared
to 49% in the controls (p 5 0.07).
Conclusion: Home care is safe. Home care and many days spent at
home were correlated to a low risk of acute GVHD.421
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Graft-versus-host disease (GVHD) is mediated by a series of path-
ophysiological events that follow transplant conditioning and are
amplified by cellular effectors and inflammatory pathways. In addi-
tion, GVHD increases oxidative stress and alters the redox environ-
ment. Whether redox dysregulation in itself potentiates the tissue
injury of GVHD is unknown. We hypothesized that redox pertuba-
tion is a proximal event that precedes target organ injury in GVHD.
To explore this, we appliedmass-spectrometry based thiol redoxme-
tabolomics to analyze the plasma and hepatic sulfur amino acid
(SAA) and thiol oxidation states in several well characterized murine
models of GVHD (Allo) and compared to syngeneic (Syn) controls,
at multiple time-points post-transplantation. Of the 38 amino-acid
metabolites profiled, significant depletion of plasma glutathione
(GSH) redox potential was noted in Allo (-127.36 16mV) compared
to Syn [158.1618 mV (p5 0.04)] mice as early as day +4 post- trans-
plantation. This change in GSH redox state was not reflected in the
cysteine (Cys/CySS) system, the principal redox couple in plasma. By
day +14 post-transplantation, further decline in plasma GSH was
noted in Allo mice while normalization of this metabolite was seen
in Syn controls. The total hepatic GSH concentration in Allo
